Indus Biotech Limited - Company Profile

It is a life sciences public limited company based in Pune, Maharashtra, India, established in 1995.
1995 Pune, Maharashtra, India Active
Last Updated:
About Indus Biotech Limited

Indus Biotech Limited, a active public limited company, was established on 16 February 1995 in Pune, Maharashtra, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: U24231MH1995PLC085656. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹43.00 Cr and a paid-up capital of ₹10.48 Cr.

Formerly known as Indus Biotech Private Limited, Indus Natural Products Private Limited. It upholds a compliant status. Employing 138 professional, Its leadership includes Rajan Ramaswamy Srinivasan (Director), Achyut Jayatirthrao Huilgol (Cfo), Ranjeet Palliyil Srinivasan (Director). Past directors included Himanshu Nivsarkar, Rajan Ramaswamy Srinivasan, Nitin Jagannath Deshmukh. It holds ₹2.93 Cr open charges and ₹22.02 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1, Rahul Residency, Plot Nos. 6 & 7, Off Salunke Vihar Road, Kondhwa, Pune, Maharashtra, 411048.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231MH1995PLC085656

  • Registration Number

    085656

  • Incorporation Date

    16 February 1995

  • Authorized Capital

    ₹43.00 Cr

  • Paid-Up Capital

    ₹10.48 Cr

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 43.00 Cr
  • Paid Up Capital ₹ 10.48 Cr
  • Company Age 30 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.93 Cr
  • Satisfied Charges ₹ 22.02 Cr
  • Revenue Growth **** -28.93%
  • Profit Growth **** -51.81%
  • Ebitda **** -57.39%
  • Net Worth 6.17%
  • Total Assets **** 5.59%
Company report

Indus Biotech Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Indus Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Indus Biotech Limited?
Current Directors
Name Designation Appointment Date Status
Rajan Ramaswamy Srinivasan Director 01 Jan 2001 Current
Achyut Jayatirthrao Huilgol Cfo 14 Mar 2018 Current
Ranjeet Palliyil Srinivasan Director 16 Feb 1995 Current
Shrikant Jayawant Patil Director 15 Nov 2021 Current
Anil Pratap Kumar Director 15 Nov 2021 Current
Pankaj Mehra Director 26 Sep 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Nominee Director 30 Jun 2025 Past
Pramod Abcsdd Whole-Time Director 16 Dec 2014 Past
Pramod Abcsdd Director 21 Sep 2021 Past
Pramod Abcsdd Director 30 Aug 2023 Past
Pramod Abcsdd Director 18 Jul 2023 Past
Pramod Abcsdd Additional Director 30 Sep 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Indus Biotech.

Indus Biotech Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.93% decrease. The company also saw a substantial fall in profitability, with a 51.81% decrease in profit. The company's net worth moved up by a moderate rise of 6.17%.

Indus Biotech revenue growth over time
Indus Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-28.93%
*******
*******
*******
*******
Revenue from Operations
*******
-26.42%
*******
*******
*******
*******
Total Assets
*******
5.59%
*******
*******
*******
*******
Profit or Loss
*******
-51.81%
*******
*******
*******
*******
Net Worth
*******
6.17%
*******
*******
*******
*******
EBITDA
*******
-57.39%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Indus Biotech?

In 2023, Indus Biotech had a promoter holding of 39.67% and a public holding of 60.34%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹29,268,000.00

Satisfied Charges

₹220,218,000.00

Charges Breakdown by Lending Institutions
  • Others : 2.00 Cr
  • Vijaya Bank : 0.93 Cr
Latest Charge Details
Date Lender Amount Status
23 Jun 2021 Others ₹2.00 Cr Open
15 Jun 2017 Vijaya Bank ₹9.27 M Open
27 Oct 2015 Others ₹13.48 Cr Satisfied
15 Oct 2011 Vijaya Bank ₹5.20 M Satisfied
25 Aug 2009 Vijaya Bank ₹4.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Indus Biotech?

Indus Biotech has a workforce of 138 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Indus Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indus Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Indus Biotech
Recent Activity within the Organization
  • Annual General Meeting

    Indus Biotech Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    The activity Pankaj Mehra was appointed as a Director was appointed as a Director on 26 Sep 2025 & has been associated with this company since 4 months 17 days . was completed.

  • Balance Sheet

    Progress on Indus Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.

  • Charges

    The activity A charge with Others of Rs. 2.00 Cr registered on 23 Jun 2021 with Charge ID 100459522 was modified on 29 Mar 2025. was completed.

  • Director Appointment

    Shrikant Jayawant Patil was appointed as a Director was appointed as a Director on 15 Nov 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.

  • Director Appointment

    Progress on Anil Pratap Kumar was appointed as a Director was appointed as a Director on 15 Nov 2021 & has been associated with this company since 4 years 2 months . was documented.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement
  • Indus Biotech news update on market trends
    Kotak PE to Sell Stake in Indus Biotech's IPO, Targets Valuation of ₹2,000 Crore.

    Kotak PE invested in Indus Biotech 11 years ago and is now planning to sell its stake in the company's upcoming IPO. The firm is targeting a valuation of around ₹2,000 crore and has hired ICICI Securities and IIFL as advisers. Indus Biotech manufactures dietary ingredients and has been granted 169 patents. Kotak PE has been an active investor in pharmaceutical, healthcare, and wellness segments..

    mint

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Indus Biotech Limited?

The CIN of Indus Biotech Limited is U24231MH1995PLC085656.

Where is Indus Biotech Limited headquartered?

Indus Biotech Limited is headquartered at 1, Rahul Residency, Plot Nos. 6 & 7, Off Salunke Vihar Road, Kondhwa, Pune, Maharashtra, 411048.

When was Indus Biotech Limited incorporated?

Indus Biotech Limited was incorporated on 16 February 1995.

Who are the current directors of Indus Biotech Limited?

The current directors of Indus Biotech Limited are

What is the primary industry of Indus Biotech Limited?

The primary industry of Indus Biotech Limited is Manufacturing.

Is Indus Biotech Limited a listed company?

Indus Biotech Limited is unlisted.

What is the capital structure of Indus Biotech Limited?

The authorized capital of Indus Biotech Limited is ₹43.00 Cr, and the paid-up capital is ₹10.48 Cr.

What is the compliance status of Indus Biotech Limited?

The compliance status of Indus Biotech Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available